GENE THERAPY FOR CANCER TREATMENT: CONTEMPORARY APPROACHES AND PRINCIPLES
Bibliographic record
Abstract
Cancer is a complicated illness in which certain cells in the body proliferate uncontrollably, encroaching on neighboring tissues. It is a significant global public health concern. Despite extensive preclinical research on achieving tumor-selective effects, various challenges hinder its effective clinical application, such as nonspecific effects, poor delivery efficiency, and biosecurity concerns. Various novel genetic methods are being developed to modify vectors or transgenes to enhance their safety and efficacy. With the newest delivery technologies, gene activity can now be precisely targeted to specific tissues and organs. With these developments, gene therapy is set to be poised for standard cancer treatment, potentially elevating this approach to a primary therapy for malignant diseases. Numerous clinical trials carried out in the USA, Europe, Canada, and China with sanctioned protocols, have demonstrated positive outcomes. Nevertheless, as our understanding of cancer mechanisms improves, innovative approaches like gene therapy will be favored over conventional treatment methods for identifying suitable treatments and targets. Gene therapy aimed at treating cancer has advanced significantly over the years, ; numerous medications have been approved, while others remain under investigation. Gene therapy offers enhanced safety and more manageable side effects than chemotherapy for treating cancer.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.002 | 0.001 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.002 | 0.001 |
| Science and technology studies | 0.001 | 0.004 |
| Scholarly communication | 0.003 | 0.002 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.002 | 0.004 |
| Insufficient payload (model declined to judge) | 0.002 | 0.002 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".